Breaking News Instant updates and real-time market news.

SPHHF

Sophos Group

$0.00 /

+ (+0.00%)

04:45
07/22/19
07/22
04:45
07/22/19
04:45

Sophos Group initiated with a Buy at Jefferies

Jefferies analyst Julian Serafini started Sophos Group with a Buy rating and 540p price target. The analyst believes fiscal 2020 expectations are now achievable.

SPHHF Sophos Group
$0.00 /

+ (+0.00%)

07/02/19 JPMorgan
Sophos Group upgraded to Overweight from Neutral at JPMorgan
11/07/18 JPMorgan
Sophos Group downgraded to Neutral from Overweight at JPMorgan
09/17/18 Deutsche Bank
Sophos Group downgraded to Hold from Buy at Deutsche Bank

TODAY'S FREE FLY STORIES

Earnings
Ceva reports Q2 non-GAAP EPS 12c, consensus 4c » 07:10
08/10/20
08/10
07:10
08/10/20
07:10
CEVA

Ceva

$42.01 /

+0.67 (+1.62%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CEVA Ceva
$42.01 /

+0.67 (+1.62%)

CEVA Ceva
$42.01 /

+0.67 (+1.62%)

07/16/20 Roth Capital
Ceva price target raised to $50 from $40 at Roth Capital
06/04/20 Northland
Ceva downgraded to Market Perform from Outperform at Northland
03/30/20 Northland
Ceva upgraded to Outperform from Market Perform at Northland
02/18/20 Roth Capital
Ceva price target raised to $40 from $35 at Roth Capital
CEVA Ceva
$42.01 /

+0.67 (+1.62%)

Earnings
Xeris Pharmaceuticals reports Q2 EPS (63c), consensus (73c) » 07:10
08/10/20
08/10
07:10
08/10/20
07:10
XERS

Xeris Pharmaceuticals

$3.36 /

+0.17 (+5.33%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
02/18/20 Piper Sandler
Xeris Pharmaceuticals initiated with an Overweight at Piper Sandler
XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

  • 26
    Jun
  • 12
    Feb
XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

Hot Stocks
Voyager Therapeutics expects cash to be sufficient into mid-2022 » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
VYGR

Voyager Therapeutics

$11.24 /

+0.24 (+2.18%)

Based on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

08/05/20 Benchmark
Voyager 'break up' with AbbVie has no impact on valuation, says Benchmark
08/04/20 H.C. Wainwright
Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright
03/30/20 Nomura Instinet
Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet
03/19/20
Fly Intel: Top five analyst initiations
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

Earnings
Black Knight sees FY20 adjusted EPS 1.94-$1.99, consensus $1.93 » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
BKI

Black Knight

$76.74 /

+1.09 (+1.44%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$76.74 /

+1.09 (+1.44%)

BKI Black Knight
$76.74 /

+1.09 (+1.44%)

07/23/20 Keefe Bruyette
Black Knight upgraded to Outperform from Market Perform at Keefe Bruyette
06/29/20 Zelman
Black Knight added as Buy to Top Idea Basket at Zelman
05/06/20 Stephens
Stephens names Black Knight as a Best Idea
05/06/20 Wells Fargo
Black Knight price target raised to $85 from $80 at Wells Fargo
BKI Black Knight
$76.74 /

+1.09 (+1.44%)

  • 17
    Jun
Earnings
Voyager Therapeutics reports Q2 EPS (23c), consensus (72c) » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
VYGR

Voyager Therapeutics

$11.24 /

+0.24 (+2.18%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

08/05/20 Benchmark
Voyager 'break up' with AbbVie has no impact on valuation, says Benchmark
08/04/20 H.C. Wainwright
Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright
03/30/20 Nomura Instinet
Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet
03/19/20
Fly Intel: Top five analyst initiations
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

Initiation
Concrete Pumping initiated with a Neutral at UBS » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
BBCP

Concrete Pumping

$4.17 /

+0.24 (+6.11%)

UBS analyst Steven Fisher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

06:35 Today UBS
Concrete Pumping initiated with a Neutral at UBS
04/03/20 B. Riley FBR
Concrete Pumping downgraded on weakening markets at B. Riley FBR
04/03/20 B. Riley FBR
Concrete Pumping downgraded to Neutral from Buy at B. Riley FBR
03/24/20 Baird
Concrete Pumping downgraded to Neutral from at Baird
BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

Earnings
Apyx Medical not providing FY20 guidance 'at this time' » 07:08
08/10/20
08/10
07:08
08/10/20
07:08
APYX

Apyx Medical

$4.90 /

-0.08 (-1.61%)

Apyx Medical said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

06/22/20 Piper Sandler
Apyx Medical's expanded international sale 'important', says Piper Sandler
03/17/20 Piper Sandler
Apyx Medical price target lowered to $7 from $10 at Piper Sandler
01/13/20 JMP Securities
Apyx Medical shares likely to continue to appreciate, says JMP Securities
11/11/19 Piper Jaffray
Apyx Medical price target raised to $10 from $8 at Piper Jaffray
APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

Initiation
PolyPid initiated with a Buy at Alliance Global Partners » 07:08
08/10/20
08/10
07:08
08/10/20
07:08
PYPD

PolyPid

$14.36 /

+0.15 (+1.06%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPD PolyPid
$14.36 /

+0.15 (+1.06%)

PYPD PolyPid
$14.36 /

+0.15 (+1.06%)

07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
07/21/20 BMO Capital
PolyPid initiated with an Outperform at BMO Capital
07/21/20 Barclays
PolyPid initiated with an Overweight at Barclays
  • 26
    Jun
PYPD PolyPid
$14.36 /

+0.15 (+1.06%)

Hot Stocks
DouYu receives proposal letter from Tencent for merger with Huya » 07:08
08/10/20
08/10
07:08
08/10/20
07:08
DOYU

DouYu

$15.23 /

-0.67 (-4.21%)

DouYu International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOYU DouYu
$15.23 /

-0.67 (-4.21%)

05/27/20 JPMorgan
DouYu upgraded to Overweight from Neutral at JPMorgan
12/05/19 Jefferies
DouYu initiated with a Buy at Jefferies
12/02/19 JPMorgan
DouYu downgraded to Neutral from Overweight at JPMorgan
12/02/19 Morgan Stanley
DouYu downgraded to Equal Weight from Overweight at Morgan Stanley
DOYU DouYu
$15.23 /

-0.67 (-4.21%)

Earnings
Apyx Medical reports Q2 EPS (14c), consensus (21c) » 07:08
08/10/20
08/10
07:08
08/10/20
07:08
APYX

Apyx Medical

$4.90 /

-0.08 (-1.61%)

Reports Q2 revenue $4.3M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

06/22/20 Piper Sandler
Apyx Medical's expanded international sale 'important', says Piper Sandler
03/17/20 Piper Sandler
Apyx Medical price target lowered to $7 from $10 at Piper Sandler
01/13/20 JMP Securities
Apyx Medical shares likely to continue to appreciate, says JMP Securities
11/11/19 Piper Jaffray
Apyx Medical price target raised to $10 from $8 at Piper Jaffray
APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

Earnings
Black Knight reports Q2 adjusted EPS 52c, consensus 47c » 07:08
08/10/20
08/10
07:08
08/10/20
07:08
BKI

Black Knight

$76.74 /

+1.09 (+1.44%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$76.74 /

+1.09 (+1.44%)

BKI Black Knight
$76.74 /

+1.09 (+1.44%)

07/23/20 Keefe Bruyette
Black Knight upgraded to Outperform from Market Perform at Keefe Bruyette
06/29/20 Zelman
Black Knight added as Buy to Top Idea Basket at Zelman
05/06/20 Stephens
Stephens names Black Knight as a Best Idea
05/06/20 Wells Fargo
Black Knight price target raised to $85 from $80 at Wells Fargo
BKI Black Knight
$76.74 /

+1.09 (+1.44%)

  • 17
    Jun
Hot Stocks
Neos Therapeutics plans to initiate Phase 1 trial of NT0502 in Q4 » 07:07
08/10/20
08/10
07:07
08/10/20
07:07
NEOS

Neos Therapeutics

$0.72 /

+0.0059 (+0.82%)

The Company plans to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEOS Neos Therapeutics
$0.72 /

+0.0059 (+0.82%)

NEOS Neos Therapeutics
$0.72 /

+0.0059 (+0.82%)

Hot Stocks
Bruker supports international COVID-19-NMR consortium » 07:07
08/10/20
08/10
07:07
08/10/20
07:07
BRKR

Bruker

$44.14 /

+0.49 (+1.12%)

Bruker announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRKR Bruker
$44.14 /

+0.49 (+1.12%)

BRKR Bruker
$44.14 /

+0.49 (+1.12%)

08/04/20 Wells Fargo
Bruker price target raised to $52 from $42 at Wells Fargo
08/04/20 SVB Leerink
Bruker price target raised to $50 from $45 at SVB Leerink
05/07/20 Wells Fargo
Bruker price target lowered to $42 from $50 at Wells Fargo
05/01/20 Cleveland Research
Bruker downgraded to Neutral at Cleveland Research
BRKR Bruker
$44.14 /

+0.49 (+1.12%)

BRKR Bruker
$44.14 /

+0.49 (+1.12%)

Earnings
Neos Therapeutics reports Q2 EPS (11c), consensus (13c) » 07:07
08/10/20
08/10
07:07
08/10/20
07:07
NEOS

Neos Therapeutics

$0.72 /

+0.0059 (+0.82%)

Reports Q revenue $13.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEOS Neos Therapeutics
$0.72 /

+0.0059 (+0.82%)

NEOS Neos Therapeutics
$0.72 /

+0.0059 (+0.82%)

Earnings
Duke Energy backs FY20 adjusted EPS view $5.05-$5.45, consensus $5.07 » 07:07
08/10/20
08/10
07:07
08/10/20
07:07
DUK

Duke Energy

$86.62 /

+2.365 (+2.81%)

Five-year, $56B capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
07/06/20 JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

  • 19
    Nov
DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

Earnings
Intercept sees 2020 Ocaliva sales $300M-$320M » 07:06
08/10/20
08/10
07:06
08/10/20
07:06
ICPT

Intercept

$48.75 /

+1.63 (+3.46%)

Revenue consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ICPT Intercept
$48.75 /

+1.63 (+3.46%)

ICPT Intercept
$48.75 /

+1.63 (+3.46%)

07/30/20 Piper Sandler
Intercept initiated with an Overweight at Piper Sandler
07/21/20 JMP Securities
Intercept downgraded to Market Perform from Outperform at JMP Securities
06/30/20 Citi
Citi upgrades Intercept following pullback ahead of likely NDA refiling
06/30/20 Citi
Intercept upgraded to Buy from Neutral at Citi
ICPT Intercept
$48.75 /

+1.63 (+3.46%)

ICPT Intercept
$48.75 /

+1.63 (+3.46%)

Earnings
Duke Energy reports Q2 EPS $1.08, consensus $1.03 » 07:05
08/10/20
08/10
07:05
08/10/20
07:05
DUK

Duke Energy

$86.62 /

+2.365 (+2.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
07/06/20 JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

  • 19
    Nov
DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

DUK Duke Energy
$86.62 /

+2.365 (+2.81%)

Downgrade
Brookfield Renewable downgraded to Hold from Buy at Industrial Alliance » 07:05
08/10/20
08/10
07:05
08/10/20
07:05
BEP

Brookfield Renewable

$45.23 /

+1.25 (+2.84%)

Industrial Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BEP Brookfield Renewable
$45.23 /

+1.25 (+2.84%)

BEP Brookfield Renewable
$45.23 /

+1.25 (+2.84%)

07/22/20 National Bank
Brookfield Renewable downgraded to Sector Perform from Outperform at National Bank
07/21/20 Credit Suisse
Brookfield Renewable price target raised to C$68 from C$64 at Credit Suisse
06/08/20 Credit Suisse
Brookfield Renewable reinstated with a Neutral at Credit Suisse
05/15/20
Fly Intel: Top five analyst initiations
BEP Brookfield Renewable
$45.23 /

+1.25 (+2.84%)

Hot Stocks
Intercept no longer expects to launch OCA for NASH in 2020 » 07:04
08/10/20
08/10
07:04
08/10/20
07:04
ICPT

Intercept

$48.75 /

+1.63 (+3.46%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICPT Intercept
$48.75 /

+1.63 (+3.46%)

ICPT Intercept
$48.75 /

+1.63 (+3.46%)

07/30/20 Piper Sandler
Intercept initiated with an Overweight at Piper Sandler
07/21/20 JMP Securities
Intercept downgraded to Market Perform from Outperform at JMP Securities
06/30/20 Citi
Citi upgrades Intercept following pullback ahead of likely NDA refiling
06/30/20 Citi
Intercept upgraded to Buy from Neutral at Citi
ICPT Intercept
$48.75 /

+1.63 (+3.46%)

ICPT Intercept
$48.75 /

+1.63 (+3.46%)

Earnings
Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year » 07:04
08/10/20
08/10
07:04
08/10/20
07:04
CGC

Canopy Growth

$16.64 /

-0.87 (-4.97%)

Reports Q2 C$119,088 up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$16.64 /

-0.87 (-4.97%)

CGC Canopy Growth
$16.64 /

-0.87 (-4.97%)

07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
06/01/20 Canaccord
Canopy Growth price target lowered to C$21 from C$23 at Canaccord
06/01/20 Scotiabank
Canopy Growth price target lowered to C$28 from C$33 at Scotiabank
CGC Canopy Growth
$16.64 /

-0.87 (-4.97%)

CGC Canopy Growth
$16.64 /

-0.87 (-4.97%)

CGC Canopy Growth
$16.64 /

-0.87 (-4.97%)

CGC Canopy Growth
$16.64 /

-0.87 (-4.97%)

Earnings
Superior Energy reports Q2 EPS ($3.97), consensus ($3.18) » 07:04
08/10/20
08/10
07:04
08/10/20
07:04
SPN

Superior Energy

$1.16 /

+ (+0.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPN Superior Energy
$1.16 /

+ (+0.00%)

SPN Superior Energy
$1.16 /

+ (+0.00%)

05/22/20 RBC Capital
Superior Energy downgraded to Underperform from Sector Perform at RBC Capital
03/19/20 Wolfe Research
Superior Energy downgraded to Underperform from Outperform at Wolfe Research
03/09/20 Evercore ISI
Superior Energy downgraded to In Line from Outperform at Evercore ISI
SPN Superior Energy
$1.16 /

+ (+0.00%)

Earnings
Consol Energy says FY20 guidance 'remains suspended' » 07:04
08/10/20
08/10
07:04
08/10/20
07:04
CEIX

Consol Energy

$5.19 /

+0.215 (+4.33%)

Consol Energy said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CEIX Consol Energy
$5.19 /

+0.215 (+4.33%)

CEIX Consol Energy
$5.19 /

+0.215 (+4.33%)

07/15/20 B. Riley FBR
Consol Energy price target raised to $10 from $8 at B. Riley FBR
02/19/20 Benchmark
Benchmark starts Consol Energy at Buy, says 'plenty of bad news' priced in
02/19/20 Benchmark
Consol Energy initiated with a Buy at Benchmark
CEIX Consol Energy
$5.19 /

+0.215 (+4.33%)

Upgrade
Cemex upgraded to Market Perform from Underperform at BBVA » 07:03
08/10/20
08/10
07:03
08/10/20
07:03
CX

Cemex

$3.31 /

+0.015 (+0.46%)

BBVA analyst Francisco…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CX Cemex
$3.31 /

+0.015 (+0.46%)

CX Cemex
$3.31 /

+0.015 (+0.46%)

07/17/20
Fly Intel: Top five analyst upgrades
07/17/20 Loop Capital
Cemex upgraded to Hold from Sell at Loop Capital
07/15/20 Credit Suisse
Cemex upgraded to Outperform at Credit Suisse
07/15/20 Credit Suisse
Cemex upgraded to Outperform from Neutral at Credit Suisse
CX Cemex
$3.31 /

+0.015 (+0.46%)

Earnings
Intercept reports Q2 EPS ($1.92), consensus ($2.92) » 07:03
08/10/20
08/10
07:03
08/10/20
07:03
ICPT

Intercept

$48.75 /

+1.63 (+3.46%)

Reports Q revenue $77.2M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ICPT Intercept
$48.75 /

+1.63 (+3.46%)

ICPT Intercept
$48.75 /

+1.63 (+3.46%)

07/30/20 Piper Sandler
Intercept initiated with an Overweight at Piper Sandler
07/21/20 JMP Securities
Intercept downgraded to Market Perform from Outperform at JMP Securities
06/30/20 Citi
Citi upgrades Intercept following pullback ahead of likely NDA refiling
06/30/20 Citi
Intercept upgraded to Buy from Neutral at Citi
ICPT Intercept
$48.75 /

+1.63 (+3.46%)

ICPT Intercept
$48.75 /

+1.63 (+3.46%)

Earnings
Consol Energy reports Q2 total coal revenue $102.03M vs. $350.62M last year » 07:03
08/10/20
08/10
07:03
08/10/20
07:03
CEIX

Consol Energy

$5.19 /

+0.215 (+4.33%)

"The second quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CEIX Consol Energy
$5.19 /

+0.215 (+4.33%)

CEIX Consol Energy
$5.19 /

+0.215 (+4.33%)

07/15/20 B. Riley FBR
Consol Energy price target raised to $10 from $8 at B. Riley FBR
02/19/20 Benchmark
Benchmark starts Consol Energy at Buy, says 'plenty of bad news' priced in
02/19/20 Benchmark
Consol Energy initiated with a Buy at Benchmark
CEIX Consol Energy
$5.19 /

+0.215 (+4.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.